Elevated Baseline C-Reactive Protein as a Predictor of Outcome After Aneurysmal Subarachnoid Hemorrhage: Data From the Simvastatin in Aneurysmal Subarachnoid Hemorrhage (STASH) Trial

There remains a proportion of patients with unfavorable outcomes after aneurysmal subarachnoid hemorrhage, of particular relevance in those who present with a good clinical grade. A forewarning of those at risk provides an opportunity towards more intensive monitoring, investigation, and prophylacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Carole L., Budohoski, Karol, Smith, Christopher, Hutchinson, Peter J., Kirkpatrick, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neurosurgery 2015
Materias:
Research—Human—Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605277/
https://www.ncbi.nlm.nih.gov/pubmed/26280117
http://dx.doi.org/10.1227/NEU.0000000000000963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605277/
https://www.ncbi.nlm.nih.gov/pubmed/26280117
http://dx.doi.org/10.1227/NEU.0000000000000963

Ejemplares similares